Health News (Reuters)

U.S. prices for multiple sclerosis drugs are on the rise

(Reuters Health) - Annual costs of disease modifying treatments for multiple sclerosis more than quadrupled from 2006 to 2016 as several new, costly medicines entered the market, a U.S. study suggests.

FDA gives fast track status to AstraZeneca's diabetes drug Farxiga

AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration has granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with chronic kidney disease (CKD).

Factbox: Oklahoma judge finds J&J liable in first trial over opioids

An Oklahoma judge on Monday ruled that Johnson & Johnson was liable for its part in fueling the opioid epidemic and ordered the drugmaker to pay $572 million following a trial in a lawsuit brought by the state's attorney general. J&J said it would appeal the decision.

More plant protein tied to longer life

(Reuters Health) - People who eat more plant-based protein may live longer than those who get more protein from meat, a Japanese study suggests.

Cancer doctors don't focus on lifestyle risks

(Reuters Health) - Cancer specialists only rarely advise patients on lifestyle changes that could improve overall health and possibly also reduce the risk of recurrence, a new survey suggests.

DEA to expand marijuana research after years of delay

The U.S. Drug Enforcement Administration said on Monday that it will move ahead with a long-delayed expansion of its marijuana research program, in a sign that the Trump administration's hostility to the drug may be waning as a growing number of states have legalized its use.

Customers can make fast-food combo meals healthier

(Reuters Health) - Combination meals in U.S. fast food and fast casual restaurants have lots of calories, saturated fat, sugar and sodium, but customers can make the meals healthier by substituting drinks and toppings, researchers say.

Oklahoma judge to rule in $17 billion opioid lawsuit against J&J

An Oklahoma judge on Monday will decide whether Johnson & Johnson should be held liable in a $17 billion lawsuit alleging the drugmaker's marketing practices fueled the opioid epidemic by causing a flood of painkillers in the market.

China says U.S. can do more to reduce fentanyl demand

The U.S. government can do more to reduce demand for fentanyl and should stop shifting the blame onto others, China said on Monday, in another riposte to Trump administration criticism that China is not helping resolve the drug problem.

Pages